Ignite Creation Date:
2025-12-24 @ 4:09 PM
Ignite Modification Date:
2026-01-20 @ 11:27 PM
Study NCT ID:
NCT02315066
Status:
COMPLETED
Last Update Posted:
2022-04-21
First Post:
2014-12-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neoplasms | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Immunotherapy | View |
| None | PF-04518600 | View |
| None | PF-05082566 | View |
| None | solid tumors | View |
| None | tumors | View |
| None | neoplasm metastasis | View |
| None | Phase 1 | View |
| None | hepatocellular carcinoma | View |
| None | HCC | View |
| None | liver cancer | View |
| None | ocular melanoma | View |
| None | melanoma | View |
| None | clear cell renal cell carcinoma | View |
| None | RCC | View |
| None | kidney cancer | View |
| None | head and neck squamous cell carcinoma | View |
| None | HNSCC | View |
| None | head and neck cancer | View |
| None | cervical cancer | View |
| None | cancer of the cervix | View |
| None | gastric cancer | View |
| None | stomach cancer | View |
| None | non small cell lung cancer | View |
| None | NSCLC | View |
| None | lung cancer | View |
| None | urothelial bladder carcinoma | View |
| None | bladder cancer | View |
| None | OX40 | View |
| None | 4-1BB | View |